...
首页> 外文期刊>Japanese Journal of Pharmacology >Chronotropic, Inotropic, Dromotropic and Coronary Vasodilator Effects of Bisaramil, a New Class I Antiarrhythmic Drug, Assessed Using Canine Isolated, Blood-Perfused Heart Preparations
【24h】

Chronotropic, Inotropic, Dromotropic and Coronary Vasodilator Effects of Bisaramil, a New Class I Antiarrhythmic Drug, Assessed Using Canine Isolated, Blood-Perfused Heart Preparations

机译:使用犬离体血液灌注心脏制剂评估新型I类抗心律不齐药物Bisaramil对慢性,正性肌力,同向性和冠状血管舒张功能的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

References(10) Cited-By(1) The cardiovascular effects of a new class I antiarrhythmic drug, bisaramil, were examined using canine isolated, blood-perfused heart preparations. Bisaramil exerted negative chronotropic, inotropic and dromotropic effects as well as coronary vasodilator action, which are qualitatively the same as those of classical class I drugs. The selectivity of bisaramil for the intraventricular conduction vs the other cardiac variables was compared with that of disopyramide and flecainide. Bisaramil was the most selective for intraventricular conduction, while it was the least selective for ventricular muscle contraction. We conclude that bisaramil may become a useful antiarrhythmic drug with less cardiac adverse effects.
机译:参考文献(10)被引用(1)使用犬离体血液灌注心脏制剂检查了一种新的I类抗心律不齐药物bisaramil的心血管作用。 Bisaramil发挥了负面的变时,正性肌力和变通性作用以及冠脉血管舒张作用,在质量上与经典的I类药物相同。比较了Bisaramil对脑室内传导的选择性与其他心脏变量的选择性,以及对diopyramide和flecainide的选择性。 Bisaramil对心室内传导的选择性最高,而对心室肌肉收缩的选择性最低。我们得出的结论是,bisaramil可能会成为一种有用的抗心律不齐药物,对心脏的不良影响较小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号